These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
334 related articles for article (PubMed ID: 22473458)
1. Effects of valsartan, an angiotensin II receptor blocker, on coronary atherosclerosis in patients with acute myocardial infarction who receive an angiotensin-converting enzyme inhibitor. Yano H; Hibi K; Nozawa N; Ozaki H; Kusama I; Ebina T; Kosuge M; Tsukahara K; Okuda J; Morita S; Umemura S; Kimura K Circ J; 2012; 76(6):1442-51. PubMed ID: 22473458 [TBL] [Abstract][Full Text] [Related]
2. The effect of valsartan, captopril, or both on atherosclerotic events after acute myocardial infarction: an analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT). McMurray J; Solomon S; Pieper K; Reed S; Rouleau J; Velazquez E; White H; Howlett J; Swedberg K; Maggioni A; Køber L; Van de Werf F; Califf R; Pfeffer M J Am Coll Cardiol; 2006 Feb; 47(4):726-33. PubMed ID: 16487836 [TBL] [Abstract][Full Text] [Related]
3. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option. Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075 [TBL] [Abstract][Full Text] [Related]
10. Effect of angiotensin receptor blockade and antihypertensive drugs on diastolic function in patients with hypertension and diastolic dysfunction: a randomised trial. Solomon SD; Janardhanan R; Verma A; Bourgoun M; Daley WL; Purkayastha D; Lacourcière Y; Hippler SE; Fields H; Naqvi TZ; Mulvagh SL; Arnold JM; Thomas JD; Zile MR; Aurigemma GP; Lancet; 2007 Jun; 369(9579):2079-87. PubMed ID: 17586303 [TBL] [Abstract][Full Text] [Related]
11. Inhibitory effect of valsartan against progression of left ventricular dysfunction after myocardial infarction: T-VENTURE study. Suzuki H; Geshi E; Nanjyo S; Nakano H; Yamazaki J; Sato N; Tanaka K; Takano T; Yagi H; Shibata T; Mochizuki S; Katagiri T Circ J; 2009 May; 73(5):918-24. PubMed ID: 19346662 [TBL] [Abstract][Full Text] [Related]
12. Valsartan, captopril, or both in myocardial infarction. Jorde UP N Engl J Med; 2004 Feb; 350(9):943-5; author reply 943-5. PubMed ID: 14988936 [No Abstract] [Full Text] [Related]
13. Valsartan, captopril, or both in myocardial infarction. Moshenyat R; Kupfer Y; Tessler S N Engl J Med; 2004 Feb; 350(9):943-5; author reply 943-5. PubMed ID: 14988935 [No Abstract] [Full Text] [Related]
14. Valsartan in the treatment of heart failure or left ventricular dysfunction after myocardial infarction. Bissessor N; White H Vasc Health Risk Manag; 2007; 3(4):425-30. PubMed ID: 17969373 [TBL] [Abstract][Full Text] [Related]
15. Dual renin angiotensin system blockade in patients with acute myocardial infarction and preserved left ventricular systolic function. Suşan M; Petrescu L; Riviş AI; Suşan RM; Burghină D; Dan R; Cozma D; Drăgulescu SI Rom J Intern Med; 2005; 43(3-4):187-98. PubMed ID: 16812979 [TBL] [Abstract][Full Text] [Related]
16. Effects of aliskiren in diabetic and non-diabetic patients with coronary artery disease: Insights from AQUARIUS. Puri R; Nissen SE; Menon V; Shao M; Hsu A; Bakris GL; Kastelein JJ; Williams B; Armbrecht J; Brunel P; Kataoka Y; Nicholls SJ Atherosclerosis; 2015 Dec; 243(2):553-9. PubMed ID: 26523993 [TBL] [Abstract][Full Text] [Related]
17. [When after myocardial infarction a pump weakness remains. ACE inhibitors and AT-1 blockers equivalent]. MMW Fortschr Med; 2003 Dec; 145(49):18-9. PubMed ID: 14963986 [No Abstract] [Full Text] [Related]
18. Impact of olmesartan on progression of coronary atherosclerosis a serial volumetric intravascular ultrasound analysis from the OLIVUS (impact of OLmesarten on progression of coronary atherosclerosis: evaluation by intravascular ultrasound) trial. Hirohata A; Yamamoto K; Miyoshi T; Hatanaka K; Hirohata S; Yamawaki H; Komatsubara I; Murakami M; Hirose E; Sato S; Ohkawa K; Ishizawa M; Yamaji H; Kawamura H; Kusachi S; Murakami T; Hina K; Ohe T J Am Coll Cardiol; 2010 Mar; 55(10):976-82. PubMed ID: 20202514 [TBL] [Abstract][Full Text] [Related]
19. Are treatment effects of ACEI and ARB in post-MI patients homogeneous? Miura T; Yuda S Circ J; 2009 May; 73(5):820-1. PubMed ID: 19390158 [No Abstract] [Full Text] [Related]
20. Long-term outcomes of left bundle branch block in high-risk survivors of acute myocardial infarction: the VALIANT experience. Stephenson K; Skali H; McMurray JJ; Velazquez EJ; Aylward PG; Kober L; Van de Werf F; White HD; Pieper KS; Califf RM; Solomon SD; Pfeffer MA Heart Rhythm; 2007 Mar; 4(3):308-13. PubMed ID: 17341394 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]